On Demand Virtual R&D Event Replay:
“Rectifying Protein Dysfunction: RTY-694 for the Treatment of Primary Sclerosing Cholangitis”

Accessibility Statement

Our Commitment to Accessibility

Rectify is committed to making our website accessible to everyone. We have built our website in a manner to work with assistive technologies using the Worldwide Web Consortium’s Website Content Accessibility Guidelines. We continue to evaluate our website to maintain and expand its accessibility for all of our visitors.

Feedback

If you have difficulty using or accessing any element of this website or have other questions regarding other reasonable modifications or auxiliary aids, please contact us at info@rectifypharma.com

Scroll to Top